Performance Characteristics of the NeuroEXPLORER, a Next-Generation Human Brain PET/CT Imager.
Hongdi Li, Ramsey D Badawi, Simon R Cherry...
https://pubmed.ncbi.nlm.nih.gov/38871391/Actively Recruiting
Led by Universitaire Ziekenhuizen KU Leuven · Updated on 2026-04-03
300
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are using ultra-high-resolution PET imaging to study how the brain and spinal cord change during healthy aging and in neurological and psychiatric disorders such as Alzheimers disease, Parkinsons disease, amyotrophic lateral sclerosis ALS, and psychotic disorders. This study aims to understand changes in small brain regions important for these conditions and to identify early brain changes that may improve early diagnosis. Participants will undergo advanced PET scans using different tracers to measure brain metabolism, synaptic density, dopamine transporters, and tau protein buildup. These scans are combined with 3T MRI scans. The study includes healthy volunteers and patients with various brain disorders, categorized into groups based on their condition. No therapeutic interventions are given during the imaging procedures. During the study, participants will complete brain scans and undergo cognitive and clinical assessments related to memory, mood, and motor or psychiatric symptoms depending on their group. Researchers will measure tracer uptake and brain volume in small brain nuclei over an average of four years. This includes assessing correlations between brain imaging findings and clinical performance. The study runs until 2029, with ongoing monitoring and data collection to help improve diagnosis and treatment in the future.
CONDITIONS
Ultra-High Resolution PET in Aging, Neurodegeneration and Psychotic Disorders
K
Koen Van Laere, Prof. Dr.
F
Francine Reniers
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Universitaire Ziekenhuizen KU Leuven
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 day
Participants undergo ultra-high-resolution PET/CT scans of the brain using various radiotracers and 3T MRI imaging to assess brain structure and function.
1 visit (in-person)
Duration - Up to 4 years
Participants are observed over time to evaluate brain imaging outcomes and correlations with cognitive and motor function.
Follow-up visits as scheduled for imaging and assessments
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
5
Have more questions? Get in touch with our team for quick support
Hongdi Li, Ramsey D Badawi, Simon R Cherry...
https://pubmed.ncbi.nlm.nih.gov/38871391/Negar Omidvari, Ekaterina Shanina, Edwin K Leung...
https://pubmed.ncbi.nlm.nih.gov/39638433/Universitaire Ziekenhuizen KU Leuven
Lead Sponsor